120 related articles for article (PubMed ID: 37831897)
1. Disparities in outcomes and access to therapy options in hepatocellular carcinoma.
Beltrán Ponce S; Gokun Y; Douglass F; Dawson L; Miller E; Thomas CR; Pitter K; Conteh L; Diaz DA
J Natl Cancer Inst; 2024 Feb; 116(2):264-274. PubMed ID: 37831897
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
Gutin L; Yao F; Dodge JL; Grab J; Mehta N
JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395
[TBL] [Abstract][Full Text] [Related]
3. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
4. Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma.
Huang DC; Yu RL; Alqahtani S; Tamim H; Saberi B; Bonder A
Ann Hepatol; 2023; 28(5):101127. PubMed ID: 37286167
[TBL] [Abstract][Full Text] [Related]
5. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
[TBL] [Abstract][Full Text] [Related]
6. Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative.
Lee RM; Gamboa AC; Turgeon MK; Yopp A; Ryon EL; Kronenfeld JP; Goel N; Wang A; Lee AY; Luu S; Hsu C; Silberfein E; Maithel SK; Russell MC
Surg Oncol; 2020 Dec; 35():120-125. PubMed ID: 32871546
[TBL] [Abstract][Full Text] [Related]
7. Differences in outcome for patients with cholangiocarcinoma: Racial/ethnic disparity or socioeconomic factors?
Lee RM; Liu Y; Gamboa AC; Staley CA; Kooby D; Russell MC; Cardona K; Maithel SK
Surg Oncol; 2020 Sep; 34():126-133. PubMed ID: 32891317
[TBL] [Abstract][Full Text] [Related]
8. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
9. Disparities in Access to Liver Transplant Referral and Evaluation among Patients with Hepatocellular Carcinoma in Georgia.
Ross-Driscoll K; Ayuk-Arrey AT; Lynch R; McCullough LE; Roccaro G; Nephew L; Hundley J; Rubin RA; Patzer R
Cancer Res Commun; 2024 Apr; 4(4):1111-1119. PubMed ID: 38517133
[TBL] [Abstract][Full Text] [Related]
10. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma.
Yu JC; Neugut AI; Wang S; Jacobson JS; Ferrante L; Khungar V; Lim E; Hershman DL; Brown RS; Siegel AB
Cancer; 2010 Apr; 116(7):1801-9. PubMed ID: 20143441
[TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact.
Govalan R; Luu M; Lauzon M; Kosari K; Ahn JC; Rich NE; Nissen N; Roberts LR; Singal AG; Yang JD
Hepatol Commun; 2022 Jan; 6(1):223-236. PubMed ID: 34558830
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Bridging Locoregional Therapy and Sociodemographics on Survival in Hepatocellular Carcinoma Patients Undergoing Orthotopic Liver Transplantation: A United Network for Organ Sharing Population Study.
Magnetta MJ; Xing M; Zhang D; Kim HS
J Vasc Interv Radiol; 2016 Dec; 27(12):1822-1828. PubMed ID: 27692856
[TBL] [Abstract][Full Text] [Related]
14. Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States.
Ahn JC; Lauzon M; Luu M; Noureddin M; Ayoub W; Kuo A; Sundaram V; Kosari K; Nissen N; Gong J; Hendifar A; Roberts LR; Abou-Alfa GK; Singal AG; Yang JD
Hepatology; 2022 Dec; 76(6):1649-1659. PubMed ID: 35429171
[TBL] [Abstract][Full Text] [Related]
15. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
[TBL] [Abstract][Full Text] [Related]
16. Does Universal Insurance and Access to Care Influence Disparities in Outcomes for Pediatric Patients with Osteomyelitis?
Young JD; Dee EC; Levine A; Sturgeon DJ; Koehlmoos TP; Schoenfeld AJ
Clin Orthop Relat Res; 2020 Jul; 478(7):1432-1439. PubMed ID: 31725027
[TBL] [Abstract][Full Text] [Related]
17. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
18. Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study.
Beutler BD; Ulanja MB; Krishan R; Aluru V; Ndukwu ML; Hagen MM; Dupin ZD; Willyard CE; Moody AE; Boampong-Konam K; Zell SC
Cancer Control; 2020; 27(1):1073274820956615. PubMed ID: 32951450
[TBL] [Abstract][Full Text] [Related]
19. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
20. Disparities in treatment and survival in early-stage hepatocellular carcinoma in California.
Gholami S; Kleber KT; Perry LM; Abidalhassan M; McFadden NR; Bateni SB; Maguire FB; Stewart SL; Morris C; Chen M; Gaskill CE; Merkow RP; Keegan TH
J Surg Oncol; 2023 Dec; 128(8):1302-1311. PubMed ID: 37610042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]